Mechanisms and consequences of injury and repair in older organ transplants

Transplantation

Volumn 97, Issue 11, 2014, Pages 1091-1099

  Slegtenhorst, Bendix R ^a,b   Dor, Frank J M F ^b   Elkhal, Abdala ^a   Rodriguez, Hector ^a,c   Yang, Xiaoyong ^a,d   Edtinger, Karoline ^a,e   Quante, Markus ^a,f   Chong, Anita S ^g   Tullius, Stefan G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aging; Injury; Repair.; Transplantation

Indexed keywords

HEAT SHOCK PROTEIN; HEME OXYGENASE 1; PROTEASOME; REACTIVE OXYGEN METABOLITE; UBIQUITIN;

AGING; AUTOPHAGY; CELLULAR STRESS RESPONSE; CHRONIC INFLAMMATION; DONOR; DONOR AGE; HEALING; HEAT SHOCK RESPONSE; HUMAN; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; ORGAN AGE; ORGAN DONOR; ORGAN INJURY; ORGAN PRESERVATION; ORGAN SIZE; ORGAN TRANSPLANTATION; PHYSICAL PARAMETERS; PRIORITY JOURNAL; REGENERATION; REGENERATIVE ABILITY; REPERFUSION INJURY; REVIEW; TISSUE GRAFT; TRANSPLANTATION;

ADULT; AGE FACTORS; AGED; AGING; AUTOPHAGY; EUROPE; HEAT-SHOCK PROTEINS; HUMANS; ISCHEMIA; KIDNEY TRANSPLANTATION; MIDDLE AGED; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; REGENERATION; REPERFUSION INJURY; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; UBIQUITIN; YOUNG ADULT;

EID: 84902131928     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000072     Document Type: Review

References (158)

1. Noppakun K, Cosio FG, Dean PG, et al. Living donor age and kidney transplant outcomes. Am J Transplant 2011; 11: 1279.
2. Moers C, Kornmann NS, Leuvenink HG, et al. The influence of deceased donor age and old-for-old allocation on kidney transplant outcome. Transplantation 2009; 88: 542.
3. de Fijter JW, Mallat MJ, Doxiadis II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
4. Tullius SG, Milford E. Kidney allocation and the aging immune response. N Engl J Med 2011; 364: 1369.
5. Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-Analysis. Nephrol Dial Transplant 2009; 24: 1039.
6. Guedes AM, Malheiro J, Fonseca I, et al. Over ten-year kidney graft survival determinants. Int J Nephrol 2012; 2012: 302974.
7. Chavalitdhamrong D, Gill J, Takemoto S, et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the organ procurement transplant Network/United network of organ sharing database. Transplantation 2008; 85: 1573.
8. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
9. Cameron AM, Ghobrial RM, Hiatt JR, et al. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg 2006; 244: 563.
10. Machicao VI, Bonatti H, Krishna M, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84.
11. Berenguer M, Aguilera V, Prieto M, et al. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis. Liver Transpl 2009; 15: 738.
12. Stehlik J, Feldman DS, Brown RN, et al. Interactions among donor characteristics influence post-Transplant survival: a multi-institutional analysis. J Heart Lung Transplant 2010; 29: 291.
13. Axelrod DA, Sung RS, Meyer KH, et al. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 2010; 10: 837.
14. Bittle GJ, Sanchez PG, Kon ZN, et al. The use of lung donors older than 55 years: a review of the United Network of Organ Sharing database. J Heart Lung Transplant 2013; 32: 760.
15. Dahlman S, Jeppsson A, Schersten H, et al. Expanding the donor pool: lung transplantation with donors 55 years and older. Transplant Proc 2006; 38: 2691.
16. Pizanis N, Heckmann J, Tsagakis K, et al. Lung transplantation using donors 55 years and older: is it safe or just a way out of organ shortage? Eur J Cardiothorac Surg 2010; 38: 192.
17. Campisi J, dAdda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729.
18. Jeyapalan JC, Ferreira M, Sedivy JM, et al. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 2007; 128: 36.
19. Westhoff JH, Schildhorn C, Jacobi C, et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21: 327.
20. Braun H, Schmidt BM, Raiss M, et al. Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol 2012; 23: 1467.
21. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4apositive senescent cells delays ageing-Associated disorders. Nature 2011; 479: 232.
22. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-Aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244.
23. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007; 128: 83.
24. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007; 292: R18.
25. Chung HY, Sung B, Jung KJ, et al. The molecular inflammatory process in aging. Antioxid Redox Signal 2006; 8: 572.
26. Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 2010; 10: 210.
27. Rodier F, Coppe JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-Associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973.
28. Salminen A, Kauppinen A, Kaarniranta K. Emerging role of NFkappaB signaling in the induction of senescence-Associated secretory phenotype (SASP). Cell Signal 2012; 24: 835.
29. Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart. myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560.
30. Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297.
31. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232: 194.
32. Barbari A, Stephan A, Masri MA, et al. Nephron mass in kidney transplantation. Transplant Proc 2002; 34: 2401.
33. Terasaki PI, Koyama H, Cecka JM, et al. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 57: 1450.
34. De Vusser K, Lerut E, Kuypers D, et al. The predictive value of kidney allograft baseline biopsies for long-Term graft survival. J Am Soc Nephrol 2013; 24: 1913.
35. Argo CK, Northup PG, Al-Osaimi AM, et al. Systematic review of risk factors for fibrosis progression in non-Alcoholic steatohepatitis. J Hepatol 2009; 51: 371.
36. Vetelainen R, van Vliet A, Gouma DJ, et al. Steatosis as a risk factor in liver surgery. Ann Surg 2007; 245: 20.
37. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant reportV2012. J Heart Lung Transplant 2012; 31: 1052.
38. Nagji AS, Hranjec T, Swenson BR, et al. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation. Ann Thorac Surg 2010; 90: 168.
39. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008; 117: 2131.
40. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103: 2705.
41. Li H, Tanaka K, Anzai H, et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol 2006; 47: 2470.
42. Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/ reperfusion injury. Int Rev Cell Mol Biol 2012; 298: 229.
43. Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007; 292: C670.
44. Short KR, Bigelow ML, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A 2005; 102: 5618.
45. Lagouge M, Larsson NG. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J Intern Med 2013; 273: 529.
46. Lesnefsky EJ, Hoppel CL. Ischemia-reperfusion injury in the aged heart: role of mitochondria. Arch Biochem Biophys 2003; 420: 287.
47. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121.
48. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009; 46: 821.
49. Haworth RA, Hunter DR. The Ca2+-induced membrane transition in mitochondria. II Nature of the Ca2+ trigger site. Arch Biochem Biophys 1979; 195: 460.
50. Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transitiondependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006; 290: H2024.
51. Ananthakrishnan R, Kaneko M, Hwang YC, et al. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 2009; 296: H333.
52. Pi Y, Goldenthal MJ, Marin-Garcia J. Mitochondrial channelopathies in aging. J Mol Med (Berl) 2007; 85: 937.
53. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826.
54. Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 2011; 11: 807.
55. Kruger B, Krick S, Dhillon N, et al. Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 2009; 106: 3390.
56. Palmer SM, Burch LH, Mir S, et al. Donor polymorphisms in toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30.
57. Agrawal A, Agrawal S, Cao JN, et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007; 178: 6912.
58. Butcher SK, Chahal H, Nayak L, et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 2001; 70: 881.
59. Swift ME, Burns AL, Gray KL, et al. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001; 117: 1027.
60. Aprahamian T, Takemura Y, Goukassian D, et al. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol 2008; 152: 448.
61. Morelli AE, Larregina AT. Apoptotic cell-based therapies against transplant rejection: role of recipients dendritic cells. Apoptosis 2010; 15: 1083.
62. Sancho D, Joffre OP, Keller AM, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458: 899.
63. Maegawa S, Hinkal G, Kim HS, et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 2010; 20: 332.
64. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5: e1000602.
65. Agrawal A, Tay J, Yang GE, et al. Age-Associated epigenetic modifications in human DNA increase its immunogenicity. Aging (Albany NY) 2010; 2: 93.
66. Castle SC, Uyemura K, Crawford W, et al. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 1999; 107: 137.
67. Ordemann R, Hutchinson R, Friedman J, et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002; 109: 1249.
68. Rippe C, Blimline M, Magerko KA, et al. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp Gerontol 2012; 47: 45.
69. Calabrese V, Cornelius C, Cuzzocrea S, et al. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med 2011; 32: 279.
70. Hahn JS, Hu Z, Thiele DJ, et al. Genome-wide analysis of the biology of stress responses through heat shock transcription factor. Mol Cell Biol 2004; 24: 5249.
71. Kelly KJ. Heat shock (stress response) proteins and renal ischemia/ reperfusion injury. Contrib Nephrol 2005; 148: 86.
72. Kourtis N, Tavernarakis N. Cellular stress response pathways and ageing: intricate molecular relationships. EMBO J 2011; 30: 2520.
73. Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005; 353: 1489.
74. Okaya T, Blanchard J, Schuster R, et al. Age-dependent responses to hepatic ischemia/reperfusion injury. Shock 2005; 24: 421.
75. Ollinger R, Pratschke J. Role of heme oxygenase-1 in transplantation. Transpl Int 2010; 23: 1071.
76. Kotsch K, Martins PN, Klemz R, et al. Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid Redox Signal 2007; 9: 2049.
77. Ferenbach DA, Nkejabega NC, McKay J, et al. The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice. Kidney Int 2011; 79: 966.
78. Tullius SG, Nieminen-Kelha M, Reutzel-Selke A, et al. Improvement of long-Term function in renal allografts from marginal donors following the induction of heme-oxygenase-1. Transplant Proc 2001; 33: 1160.
79. Broere F, van der Zee R, van Eden W. Heat shock proteins are no DAMPs, rather DAMPERs. Nat Rev Immunol 2011; 11: 565-565.
80. Wachstein J, Tischer S, Figueiredo C, et al. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) Tregulatory cells and cytotoxicity in CD4(+)CD25(j) T cells. PLoS One 2012; 7: e51747.
81. Borges TJ, Porto BN, Teixeira CA, et al. Prolonged survival of allografts induced by mycobacterial Hsp70 is dependent on CD4+ CD25+ regulatory T cells. PLoS One 2010; 5: e14264.
82. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005; 115: 2656.
83. Brodsky JL. Cleaning up: ER-Associated degradation to the rescue. Cell 2012; 151: 1163.
84. Haynes CM, Ron D. The mitochondrial UPRVprotecting organelle protein homeostasis. J Cell Sci 2010; 123(Pt 22): 3849.
85. Szegezdi E, Logue SE, Gorman AM, et al. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006; 7: 880.
86. Inagi R. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp Nephrol 2009; 112: e1.
87. Kaplowitz N, Than TA, Shinohara M, et al. Endoplasmic reticulum stress and liver injury. Semin Liver Dis 2007; 27: 367.
88. Toth A, Nickson P, Mandl A, et al. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 2007; 7: 205.
89. Naidoo N. ER and aging-protein folding and the ER stress response. Ageing Res Rev 2009; 8: 150.
90. Breusing N, Grune T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 2008; 389: 203.
91. Ishihara Y, Hamaguchi A, Sekine M, et al. Accumulation of cytochrome P450 induced by proteasome inhibition during cardiac ischemia. Arch Biochem Biophys 2012; 527: 16.
92. Tian Z, Zheng H, Li J, et al. Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ Res 2012; 111: 532.
93. Huber JM, Tagwerker A, Heininger D, et al. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2009; 297: F451.
94. Pye J, Ardeshirpour F, McCain A, et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 2003; 284: H919.
95. Glembotski CC. Clarifying the cardiac proteasome paradox: protein quality control. Circ Res 2012; 111: 509.
96. Walsh RC, Alloway RR, Girnita AL, et al. Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int 2012; 81: 1067.
97. Murrow L, Debnath J. Autophagy as a stress-response and qualitycontrol mechanism: implications for cell injury and human disease. Annu Rev Pathol 2013; 8: 105.
98. Jiang M, Wei Q, Dong G, et al. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012; 82: 1271.
99. Wang JH, Ahn IS, Fischer TD, et al. Autophagy suppresses agedependent ischemia and reperfusion injury in livers of mice. Gastroenterology 2011; 141: 2188,2199.e6.
100. Sala-Mercado JA, Wider J, Undyala VV, et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 2010; 122 (11 Suppl): S179.
101. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagyY inflammationYcell death axis in organismal aging. Science 2011; 333: 1109.
102. Wang JH, Behrns KE, Leeuwenburgh C, et al. Critical role of autophage in ischemia/reperfusion injury to aged livers. Autophagy 2012; 8: 140.
103. Karp SJ. Clinical implications of advances in the basic science of liver repair and regeneration. Am J Transplant 2009; 9: 1973.
104. Nelson PJ, Rees AJ, Griffin MD, et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012; 23: 194.
105. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59: 311.
106. Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med 2008; 36(4 Suppl): S187.
107. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286.
108. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007; 72: 151.
109. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010; 86: 236.
110. Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F1648.
111. Regner KR, Roman RJ. Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. Curr Opin Nephrol Hypertens 2012; 21: 33.
112. Shiraha H, Gupta K, Drabik K, et al. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 2000; 275: 19343.
113. Tran KT, Rusu SD, Satish L, et al. Aging-related attenuation of EGF receptor signaling is mediated in part by increased protein tyrosine phosphatase activity. Exp Cell Res 2003; 289: 359.
114. Komi-Kuramochi A, Kawano M, Oda Y, et al. Expression of fibroblast growth factors and their receptors during full-Thickness skin wound healing in young and aged mice. J Endocrinol 2005; 186: 273.
115. Patschan D, Patschan S, Muller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells renoprotective competence. Int J Nephrol 2011; 2011: 828369.
116. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801.
117. Togel F, Isaac J, Hu Z, et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772.
118. Mazzinghi B, Ronconi E, Lazzeri E, et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008; 205: 479.
119. Patschan D, Backhaus R, Elle HJ, et al. Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner. J Nephrol 2013; 26: 667.
120. Bosch-Marce M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310.
121. Kyriakou C, Rabin N, Pizzey A, et al. Factors that influence shortterm homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 2008; 93: 1457.
122. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787.
123. Lech M, Anders HJ. Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta 2013; 1832: 989.
124. Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317.
125. Menke J, Iwata Y, Rabacal WA, et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J Clin Invest 2009; 119: 2330.
126. Lin SL, Li B, Rao S, et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A 2010; 107: 4194.
127. Mahbub S, Deburghgraeve CR, Kovacs EJ. Advanced age impairs macrophage polarization. J Interferon Cytokine Res 2012; 32: 18.
128. Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013; 123: 1858.
129. Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metab 2009; 20: 171.
130. Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: an overview. Birth Defects Res C Embryo Today 2012; 96: 1.
131. Senyo SE, Steinhauser ML, Pizzimenti CL, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013; 493: 433.
132. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763.
133. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701.
134. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98.
135. Ballard VL, Edelberg JM. Stem cells for cardiovascular repairVthe challenges of the aging heart. J Mol Cell Cardiol 2008; 45: 582.
136. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003; 14 (Suppl 1): S55.
137. Schmitt R, Marlier A, Cantley LG. Zag expression during aging suppresses proliferation after kidney injury. J Am Soc Nephrol 2008; 19: 2375.
138. Humphreys BD, Valerius MT, Kobayashi A, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284.
139. Oliver JA, Klinakis A, Cheema FH, et al. Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol 2009; 20: 2315.
140. Miya M, Maeshima A, Mishima K, et al. Age-related decline in labelretaining tubular cells: implication for reduced regenerative capacity after injury in the aging kidney. AmJ Physiol Renal Physiol 2012; 302: F694.
141. Schmitt R, Cantley LG. The impact of aging on kidney repair. Am J Physiol Renal Physiol 2008; 294: F1265.
142. Lahteenvuo J, Rosenzweig A. Effects of aging on angiogenesis. Circ Res 2012; 110: 1252.
143. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431.
144. Taylor MJ, Baicu S, Leman B, et al. Twenty-four hour hypothermic machine perfusion preservation of porcine pancreas facilitates processing for islet isolation. Transplant Proc 2008; 40: 480.
145. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10: 372.
146. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7.
147. Moers C, Pirenne J, Paul A, et al., Machine Preservation Trial Study Group. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2012; 366: 770.
148. Treckmann J, Moers C, Smits JM, et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int 2011; 24: 548.
149. Gallinat A, Moers C, Smits JM, et al. Machine perfusion versus static cold storage in expanded criteria donor kidney transplantation: 3-year follow-up data. Transpl Int 2013; 26: E52.
150. Gallinat A, Moers C, Treckmann J, et al. Machine perfusion versus cold storage for the preservation of kidneys from donors Q 65 years allocated in the Eurotransplant Senior Programme. Nephrol Dial Transplant 2012; 27: 4458.
151. Guarrera JV. Assist devices: machine preservation of extended criteria donors. Liver Transpl 2012; 18(Suppl 2): S31.
152. St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet 2002; 359: 604.
153. Gracia-Sancho J, Villarreal G Jr, Zhang Y, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation 2010; 90: 142.
154. Gallinat A, Fox M, Luer B, et al. Role of pulsatility in hypothermic reconditioning of porcine kidney grafts by machine perfusion after cold storage. Transplantation 2013; 96: 142.
155. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2011 annual data report: kidney. Am J Transplant 2013; 13(Suppl 1): 11.
156. Giessing M, Fuller TF, Friedersdorff F, et al. Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients. J Am Soc Nephrol 2009; 20: 37.
157. Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 2008; 7: 491.
158. Gingell-Littlejohn M, McGuinness D, McGlynn LM, et al. Pretransplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS One 2013; 8: e68133.